Amplia opens new front in ovarian cancer fight
--------------------------------------------------------------------
Source: The Age
Published: 2026-09-15 14:53 UTC+10:00
Section: Business / Companies
Factuality Score: 100
Opinion Category: Neutral
Topics: Science, Health, Elections, Drugs, Business & Economy
--------------------------------------------------------------------
Snippet:
Clinical-stage biotech Amplia Therapeutics has finalised plans for its PRROSE phase two ovarian cancer study, clearing a key preparatory hurdle and opening a second cancer front for its leading drug candidate narmafotinib.
--------------------------------------------------------------------